#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
AAC_2___Ic.3002525.AL123456.3.314308_314854.4719	AAC_2___Ic.3002525.AL123456.3.314308_314854.4719	1	0	27	404	AAC_2___Ic	546	546	100.0	AAC_2___Ic.l15.c4.ctg.1	1052	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	b"AAC(2')-Ic is a chromosomal-encoded aminoglycoside acetyltransferase in M. tuberculosis and Mycobacterium tuberculosis variant bovis.";AAC(2')-Ic
Erm_37_.3000392.AL123456.1.2231679_2232219.582	Erm_37_.3000392.AL123456.1.2231679_2232219.582	1	0	27	236	Erm_37_	540	540	100.0	Erm_37_.l15.c17.ctg.1	1074	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	b'Erm(37) is found in Mycobacterium species and confers the MLSb phenotype. In addition to methylation of A2058 this Erm methylates adjacent adenosines (A2057 and A2059) as well.';Erm(37)
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	528	72	Mycobacterium_intracellulare_23S_1	3103	169	97.63	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	280	0.0	0	.	n	.	0	T8C	SNP	8	8	T	119	119	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	528	72	Mycobacterium_intracellulare_23S_1	3103	169	97.63	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	280	0.0	0	.	n	.	0	A96G	SNP	96	96	A	207	207	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	528	72	Mycobacterium_intracellulare_23S_1	3103	169	97.63	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	280	0.0	0	.	n	.	0	T98G	SNP	98	98	T	209	209	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	528	72	Mycobacterium_intracellulare_23S_1	3103	169	97.63	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	280	0.0	0	.	n	.	0	T146C	SNP	146	146	T	257	257	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	1	1	783	642	Mycobacterium_tuberculosis_Rv1258c_1	1260	1260	100.0	Mycobacterium_tuberculosis_Rv1258c_1.l6.c4.ctg.1	1661	0.0	1	SNP	p	V219A	0	.	.	655	657	GTC	955	957	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483:1:1:V219A:.:b'Mutations in the M. tuberculosis efflux pump Rv1258c (Tap) conferring resistance to pyrazinamide, isoniazid, and streptomycin.'	Mycobacterium tuberculosis Rv1258c mutations confer resistance to pyrazinamide, isoniazid, and streptomycin
Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	1	1	783	642	Mycobacterium_tuberculosis_Rv1258c_1	1260	1260	100.0	Mycobacterium_tuberculosis_Rv1258c_1.l6.c4.ctg.1	1661	0.0	1	SNP	p	S292L	0	.	.	874	876	TCG	1174	1176	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483:1:1:S292L:.:b'Mutations in the M. tuberculosis efflux pump Rv1258c (Tap) conferring resistance to pyrazinamide, isoniazid, and streptomycin.'	Mycobacterium tuberculosis Rv1258c mutations confer resistance to pyrazinamide, isoniazid, and streptomycin
Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	1	1	783	642	Mycobacterium_tuberculosis_Rv1258c_1	1260	298	93.3	Mycobacterium_tuberculosis_Rv1258c_1.l6.c4.ctg.2	524	0.0	0	.	p	.	0	A282V	NONSYN	844	846	GCT	434	436	GTT	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis Rv1258c mutations confer resistance to pyrazinamide, isoniazid, and streptomycin
Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	1	1	783	642	Mycobacterium_tuberculosis_Rv1258c_1	1260	298	93.3	Mycobacterium_tuberculosis_Rv1258c_1.l6.c4.ctg.2	524	0.0	0	.	p	.	0	V285F	NONSYN	853	855	GTT	443	445	TTT	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis Rv1258c mutations confer resistance to pyrazinamide, isoniazid, and streptomycin
Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	1	1	783	642	Mycobacterium_tuberculosis_Rv1258c_1	1260	298	93.3	Mycobacterium_tuberculosis_Rv1258c_1.l6.c4.ctg.2	524	0.0	0	.	p	.	0	R287G	NONSYN	859	861	CGT	449	451	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis Rv1258c mutations confer resistance to pyrazinamide, isoniazid, and streptomycin
Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	1	1	783	642	Mycobacterium_tuberculosis_Rv1258c_1	1260	298	93.3	Mycobacterium_tuberculosis_Rv1258c_1.l6.c4.ctg.2	524	0.0	0	.	p	.	0	V289G	NONSYN	865	867	GTG	455	457	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis Rv1258c mutations confer resistance to pyrazinamide, isoniazid, and streptomycin
Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	1	1	783	642	Mycobacterium_tuberculosis_Rv1258c_1	1260	298	93.3	Mycobacterium_tuberculosis_Rv1258c_1.l6.c4.ctg.2	524	0.0	0	.	p	.	0	G299V	NONSYN	895	897	GGT	485	487	GTT	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis Rv1258c mutations confer resistance to pyrazinamide, isoniazid, and streptomycin
Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	1	1	783	642	Mycobacterium_tuberculosis_Rv1258c_1	1260	298	93.3	Mycobacterium_tuberculosis_Rv1258c_1.l6.c4.ctg.2	524	0.0	0	.	p	.	0	L344R	NONSYN	1030	1032	CTG	330	332	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis Rv1258c mutations confer resistance to pyrazinamide, isoniazid, and streptomycin
Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	1	1	783	642	Mycobacterium_tuberculosis_Rv1258c_1	1260	298	93.3	Mycobacterium_tuberculosis_Rv1258c_1.l6.c4.ctg.2	524	0.0	0	.	p	.	0	L381H	NONSYN	1141	1143	CTC	219	221	GAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis Rv1258c mutations confer resistance to pyrazinamide, isoniazid, and streptomycin
Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	1	1	783	642	Mycobacterium_tuberculosis_Rv1258c_1	1260	298	93.3	Mycobacterium_tuberculosis_Rv1258c_1.l6.c4.ctg.2	524	0.0	0	.	p	.	0	I387L	NONSYN	1159	1161	ATC	201	203	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis Rv1258c mutations confer resistance to pyrazinamide, isoniazid, and streptomycin
Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	1	1	783	642	Mycobacterium_tuberculosis_Rv1258c_1	1260	298	93.3	Mycobacterium_tuberculosis_Rv1258c_1.l6.c4.ctg.2	524	0.0	0	.	p	.	0	A394G	NONSYN	1180	1182	GCG	180	182	CGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis Rv1258c mutations confer resistance to pyrazinamide, isoniazid, and streptomycin
Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	1	1	783	642	Mycobacterium_tuberculosis_Rv1258c_1	1260	298	93.3	Mycobacterium_tuberculosis_Rv1258c_1.l6.c4.ctg.2	524	0.0	0	.	p	.	0	I395R	NONSYN	1183	1185	ATC	177	179	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis Rv1258c mutations confer resistance to pyrazinamide, isoniazid, and streptomycin
Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	1	1	783	642	Mycobacterium_tuberculosis_Rv1258c_1	1260	298	93.3	Mycobacterium_tuberculosis_Rv1258c_1.l6.c4.ctg.2	524	0.0	0	.	p	.	0	L397S	NONSYN	1189	1191	CTG	171	173	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis Rv1258c mutations confer resistance to pyrazinamide, isoniazid, and streptomycin
Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	1	1	783	642	Mycobacterium_tuberculosis_Rv1258c_1	1260	298	93.3	Mycobacterium_tuberculosis_Rv1258c_1.l6.c4.ctg.2	524	0.0	0	.	p	.	0	A399G	NONSYN	1195	1197	GCG	165	167	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis Rv1258c mutations confer resistance to pyrazinamide, isoniazid, and streptomycin
Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	1	1	783	642	Mycobacterium_tuberculosis_Rv1258c_1	1260	298	93.3	Mycobacterium_tuberculosis_Rv1258c_1.l6.c4.ctg.2	524	0.0	0	.	p	.	0	L400R	NONSYN	1198	1200	CTG	162	164	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis Rv1258c mutations confer resistance to pyrazinamide, isoniazid, and streptomycin
Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	1	1	783	642	Mycobacterium_tuberculosis_Rv1258c_1	1260	298	93.3	Mycobacterium_tuberculosis_Rv1258c_1.l6.c4.ctg.2	524	0.0	1	SNP	p	S292L	0	.	.	874	876	TCG	464	466	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483:1:1:S292L:.:b'Mutations in the M. tuberculosis efflux pump Rv1258c (Tap) conferring resistance to pyrazinamide, isoniazid, and streptomycin.'	Mycobacterium tuberculosis Rv1258c mutations confer resistance to pyrazinamide, isoniazid, and streptomycin
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	812	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c4.ctg.1	2093	0.0	1	SNP	p	R13C	0	.	.	37	39	CGT	340	342	CGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:R13C:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	812	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c4.ctg.1	2093	0.0	1	SNP	p	V18A	0	.	.	52	54	GTG	355	357	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:V18A:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	812	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c4.ctg.1	2093	0.0	1	SNP	p	L50V	0	.	.	148	150	CTG	451	453	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:L50V:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	812	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c4.ctg.1	2093	0.0	1	SNP	p	T110A	0	.	.	328	330	ACC	631	633	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:T110A:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	812	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c4.ctg.1	2093	0.0	1	SNP	p	R268H	0	.	.	802	804	CGC	1105	1107	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:R268H:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	812	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c4.ctg.1	2093	0.0	1	SNP	p	A300P	0	.	.	898	900	GCC	1201	1203	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:A300P:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	812	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c4.ctg.1	2093	0.0	1	SNP	p	G313R	0	.	.	937	939	GGG	1240	1242	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:G313R:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	812	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c4.ctg.1	2093	0.0	1	SNP	p	G339A	0	.	.	1015	1017	GGG	1318	1320	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:G339A:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	854	96.37	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.1	908	0.0	0	.	n	.	0	T741G	SNP	741	741	T	91	91	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	854	96.37	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.1	908	0.0	0	.	n	.	0	T863C	SNP	863	863	T	213	213	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	854	96.37	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.1	908	0.0	0	.	n	.	0	A870G	SNP	870	870	A	220	220	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	854	96.37	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.1	908	0.0	0	.	n	.	0	T975C	SNP	975	975	T	325	325	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	854	96.37	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.1	908	0.0	0	.	n	.	0	C977T	SNP	977	977	C	327	327	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	854	96.37	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.1	908	0.0	0	.	n	.	0	A990G	SNP	990	990	A	340	340	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	854	96.37	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.1	908	0.0	0	.	n	.	0	T1086C	SNP	1086	1086	T	436	436	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	854	96.37	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.1	908	0.0	0	.	n	.	0	G1098A	SNP	1098	1098	G	448	448	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	854	96.37	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.1	908	0.0	0	.	n	.	0	G1099C	SNP	1099	1099	G	449	449	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	854	96.37	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.1	908	0.0	0	.	n	.	0	C1107T	SNP	1107	1107	C	457	457	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	854	96.37	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.1	908	0.0	0	.	n	.	0	G1119A	SNP	1119	1119	G	469	469	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	854	96.37	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.1	908	0.0	0	.	n	.	0	A1211G	SNP	1211	1211	A	561	561	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	854	96.37	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.1	908	0.0	0	.	n	.	0	G1217A	SNP	1217	1217	G	567	567	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	854	96.37	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.1	908	0.0	0	.	n	.	0	A1228T	SNP	1228	1228	A	578	578	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	854	96.37	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.1	908	0.0	0	.	n	.	0	T1233C	SNP	1233	1233	T	583	583	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	854	96.37	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.1	908	0.0	0	.	n	.	0	A1234G	SNP	1234	1234	A	584	584	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	854	96.37	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.1	908	0.0	0	.	n	.	0	G1239T	SNP	1239	1239	G	589	589	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	854	96.37	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.1	908	0.0	0	.	n	.	0	G1240A	SNP	1240	1240	G	590	590	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	854	96.37	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.1	908	0.0	0	.	n	.	0	C1250T	SNP	1250	1250	C	600	600	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	854	96.37	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.1	908	0.0	0	.	n	.	0	T1252A	SNP	1252	1252	T	602	602	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	854	96.37	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.1	908	0.0	0	.	n	.	0	T1258C	SNP	1258	1258	T	608	608	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	854	96.37	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.1	908	0.0	0	.	n	.	0	T1274C	SNP	1274	1274	T	624	624	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	854	96.37	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.1	908	0.0	0	.	n	.	0	A1295G	SNP	1295	1295	A	645	645	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	854	96.37	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.1	908	0.0	0	.	n	.	0	T1419C	SNP	1419	1419	T	769	769	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	854	96.37	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.1	908	0.0	0	.	n	.	0	T1420G	SNP	1420	1420	T	770	770	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	854	96.37	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.1	908	0.0	1	SNP	n	A1375G	0	.	.	1375	1375	A	725	725	A	ND	ND	ND	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256:0:0:A1375G:.:b'Point mutations in the 16S rRNA of Mycobacteroides abscessus conferring resistance to gentamicin.'	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	854	96.37	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.1	908	0.0	1	SNP	n	C1376U	0	.	.	1376	1376	C	726	726	C	ND	ND	ND	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256:0:0:C1376U:.:b'Point mutations in the 16S rRNA of Mycobacteroides abscessus conferring resistance to gentamicin.'	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	854	96.37	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.1	908	0.0	1	SNP	n	G1458U	0	.	.	1458	1458	G	808	808	G	ND	ND	ND	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256:0:0:G1458U:.:b'Point mutations in the 16S rRNA of Mycobacteroides abscessus conferring resistance to gentamicin.'	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	374	93.65	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.2	484	0.0	0	.	n	.	0	C69T	SNP	69	69	C	176	176	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	374	93.65	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.2	484	0.0	0	.	n	.	0	.75A	INS	75	75	G	183	183	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	374	93.65	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.2	484	0.0	0	.	n	.	0	G77A	SNP	77	77	G	185	185	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	374	93.65	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.2	484	0.0	0	.	n	.	0	T129C	SNP	129	129	T	237	237	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	374	93.65	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.2	484	0.0	0	.	n	.	0	C174G	SNP	174	174	C	282	282	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	374	93.65	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.2	484	0.0	0	.	n	.	0	C176A	SNP	176	176	C	284	284	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	374	93.65	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.2	484	0.0	0	.	n	.	0	T178G	SNP	178	178	T	286	286	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	374	93.65	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.2	484	0.0	0	.	n	.	0	G183T	SNP	183	183	G	291	291	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	374	93.65	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.2	484	0.0	0	.	n	.	0	A186T	SNP	186	186	A	294	294	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	374	93.65	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.2	484	0.0	0	.	n	.	0	C193G	SNP	193	193	C	301	301	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	374	93.65	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.2	484	0.0	0	.	n	.	0	.196GC	INS	196	196	A	305	305	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	374	93.65	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.2	484	0.0	0	.	n	.	0	T202A	SNP	202	202	T	312	312	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	374	93.65	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.2	484	0.0	0	.	n	.	0	G245A	SNP	245	245	G	355	355	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	374	93.65	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.2	484	0.0	0	.	n	.	0	T249C	SNP	249	249	T	359	359	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	374	93.65	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.2	484	0.0	0	.	n	.	0	C254T	SNP	254	254	C	364	364	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	128	Mycobacteroides_abscessus_16S_4	1504	374	93.65	Mycobacteroides_abscessus_16S_4.l15.c30.ctg.2	484	0.0	0	.	n	.	0	A291T	SNP	291	291	A	401	401	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	811	96.18	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.1	955	0.0	0	.	n	.	0	T721G	SNP	721	721	T	91	91	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	811	96.18	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.1	955	0.0	0	.	n	.	0	T843C	SNP	843	843	T	213	213	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	811	96.18	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.1	955	0.0	0	.	n	.	0	A850G	SNP	850	850	A	220	220	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	811	96.18	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.1	955	0.0	0	.	n	.	0	G947A	SNP	947	947	G	317	317	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	811	96.18	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.1	955	0.0	0	.	n	.	0	A956G	SNP	956	956	A	326	326	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	811	96.18	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.1	955	0.0	0	.	n	.	0	T969C	SNP	969	969	T	339	339	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	811	96.18	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.1	955	0.0	0	.	n	.	0	A970G	SNP	970	970	A	340	340	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	811	96.18	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.1	955	0.0	0	.	n	.	0	C986T	SNP	986	986	C	356	356	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	811	96.18	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.1	955	0.0	0	.	n	.	0	C1065T	SNP	1065	1065	C	435	435	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	811	96.18	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.1	955	0.0	0	.	n	.	0	T1066C	SNP	1066	1066	T	436	436	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	811	96.18	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.1	955	0.0	0	.	n	.	0	G1079C	SNP	1079	1079	G	449	449	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	811	96.18	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.1	955	0.0	0	.	n	.	0	C1086G	SNP	1086	1086	C	456	456	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	811	96.18	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.1	955	0.0	0	.	n	.	0	C1087T	SNP	1087	1087	C	457	457	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	811	96.18	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.1	955	0.0	0	.	n	.	0	A1098G	SNP	1098	1098	A	468	468	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	811	96.18	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.1	955	0.0	0	.	n	.	0	G1099A	SNP	1099	1099	G	469	469	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	811	96.18	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.1	955	0.0	0	.	n	.	0	A1191G	SNP	1191	1191	A	561	561	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	811	96.18	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.1	955	0.0	0	.	n	.	0	G1197A	SNP	1197	1197	G	567	567	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	811	96.18	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.1	955	0.0	0	.	n	.	0	A1208T	SNP	1208	1208	A	578	578	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	811	96.18	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.1	955	0.0	0	.	n	.	0	A1214G	SNP	1214	1214	A	584	584	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	811	96.18	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.1	955	0.0	0	.	n	.	0	G1220A	SNP	1220	1220	G	590	590	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	811	96.18	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.1	955	0.0	0	.	n	.	0	C1230T	SNP	1230	1230	C	600	600	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	811	96.18	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.1	955	0.0	0	.	n	.	0	T1232A	SNP	1232	1232	T	602	602	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	811	96.18	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.1	955	0.0	0	.	n	.	0	T1238C	SNP	1238	1238	T	608	608	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	811	96.18	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.1	955	0.0	0	.	n	.	0	T1254C	SNP	1254	1254	T	624	624	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	811	96.18	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.1	955	0.0	0	.	n	.	0	A1275G	SNP	1275	1275	A	645	645	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	811	96.18	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.1	955	0.0	0	.	n	.	0	T1397C	SNP	1397	1397	T	767	767	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	811	96.18	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.1	955	0.0	0	.	n	.	0	T1400G	SNP	1400	1400	T	770	770	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	811	96.18	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.1	955	0.0	1	SNP	n	A1355G	0	.	.	1355	1355	A	725	725	A	ND	ND	ND	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271:0:0:A1355G:.:b'Point mutations in the 16S rRNA of Mycobacteroides chelonae can cause resistance to neomycin.'	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	354	93.3	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.2	465	0.0	0	.	n	.	0	.47T	INS	47	47	G	155	155	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	354	93.3	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.2	465	0.0	0	.	n	.	0	C49T	SNP	49	49	C	157	157	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	354	93.3	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.2	465	0.0	0	.	n	.	0	G57A	SNP	57	57	G	166	166	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	354	93.3	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.2	465	0.0	0	.	n	.	0	C108T	SNP	108	108	C	217	217	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	354	93.3	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.2	465	0.0	0	.	n	.	0	T109C	SNP	109	109	T	218	218	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	354	93.3	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.2	465	0.0	0	.	n	.	0	A153G	SNP	153	153	A	262	262	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	354	93.3	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.2	465	0.0	0	.	n	.	0	C156A	SNP	156	156	C	265	265	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	354	93.3	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.2	465	0.0	0	.	n	.	0	T158G	SNP	158	158	T	267	267	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	354	93.3	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.2	465	0.0	0	.	n	.	0	G165T	SNP	165	165	G	274	274	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	354	93.3	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.2	465	0.0	0	.	n	.	0	A166T	SNP	166	166	A	275	275	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	354	93.3	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.2	465	0.0	0	.	n	.	0	C173G	SNP	173	173	C	282	282	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	354	93.3	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.2	465	0.0	0	.	n	.	0	.176GC	INS	176	176	A	286	286	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	354	93.3	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.2	465	0.0	0	.	n	.	0	T182A	SNP	182	182	T	293	293	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	354	93.3	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.2	465	0.0	0	.	n	.	0	G225A	SNP	225	225	G	336	336	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	354	93.3	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.2	465	0.0	0	.	n	.	0	A227G	SNP	227	227	A	338	338	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	354	93.3	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.2	465	0.0	0	.	n	.	0	T229C	SNP	229	229	T	340	340	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	354	93.3	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.2	465	0.0	0	.	n	.	0	C234T	SNP	234	234	C	345	345	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	110	Mycobacteroides_chelonae_16S_4	1441	354	93.3	Mycobacteroides_chelonae_16S_4.l15.c17.ctg.2	465	0.0	0	.	n	.	0	A271T	SNP	271	271	A	382	382	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
blaC.3007182.AL123456.3.2325885_2326809.8481	blaC.3007182.AL123456.3.2325885_2326809.8481	1	0	27	512	blaC	924	924	100.0	blaC.l15.c4.ctg.1	1572	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	b'blaC is a broad-spectrum class A beta-lactamase coded in the chromosome of Mycobacterium tuberculosis. It has been shown to hydrolyze a large number of beta-lactam antibiotics and is a major obstacle in the treatment of tuberculosis with such drugs.';blaC
efpA.3003955.AL123456.3.3153038_3154631.5259	efpA.3003955.AL123456.3.3153038_3154631.5259	1	0	27	898	efpA	1593	1593	100.0	efpA.l15.c4.ctg.1	1956	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	efpA;b'efpA is an MFS transporter found in Mycobacterium tuberculosis.'
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	1424	embA	3285	3285	100.0	embA.l15.c4.ctg.1	3711	0.0	1	SNP	p	D4N	0	.	.	10	12	GAC	267	269	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:D4N:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	1424	embA	3285	3285	100.0	embA.l15.c4.ctg.1	3711	0.0	1	SNP	p	G5S	0	.	.	13	15	GGT	270	272	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:G5S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	1424	embA	3285	3285	100.0	embA.l15.c4.ctg.1	3711	0.0	1	SNP	p	A201T	0	.	.	601	603	GCG	858	860	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:A201T:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	1424	embA	3285	3285	100.0	embA.l15.c4.ctg.1	3711	0.0	1	SNP	p	G321S	0	.	.	961	963	GGC	1218	1220	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:G321S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	1424	embA	3285	3285	100.0	embA.l15.c4.ctg.1	3711	0.0	1	SNP	p	G350D	0	.	.	1048	1050	GGC	1305	1307	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:G350D:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	1424	embA	3285	3285	100.0	embA.l15.c4.ctg.1	3711	0.0	1	SNP	p	A462V	0	.	.	1384	1386	GCG	1641	1643	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:A462V:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	1424	embA	3285	3285	100.0	embA.l15.c4.ctg.1	3711	0.0	1	SNP	p	D833A	0	.	.	2497	2499	GAC	2754	2756	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:D833A:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	1424	embA	3285	3285	100.0	embA.l15.c4.ctg.1	3711	0.0	1	SNP	p	P913S	0	.	.	2737	2739	CCG	2994	2996	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:P913S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	L239P	0	.	.	715	717	CTG	881	883	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:L239P:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	D240H	0	.	.	718	720	GAC	884	886	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D240H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	S297A	0	.	.	889	891	TCG	1055	1057	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:S297A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	D299E	0	.	.	895	897	GAC	1061	1063	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D299E:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	M306T	0	.	.	916	918	ATG	1082	1084	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M306T:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	M306V	0	.	.	916	918	ATG	1082	1084	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M306V:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	M306L	0	.	.	916	918	ATG	1082	1084	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M306L:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	M306I	0	.	.	916	918	ATG	1082	1084	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M306I:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	D311H	0	.	.	931	933	GAC	1097	1099	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D311H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	Y319N	0	.	.	955	957	TAT	1121	1123	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Y319N:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	Y319C	0	.	.	955	957	TAT	1121	1123	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Y319C:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	D328G	0	.	.	982	984	GAT	1148	1150	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D328G:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	D328Y	0	.	.	982	984	GAT	1148	1150	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D328Y:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	F330V	0	.	.	988	990	TTC	1154	1156	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:F330V:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	Y333C	0	.	.	997	999	TAT	1163	1165	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Y333C:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	Y334H	0	.	.	1000	1002	TAC	1166	1168	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Y334H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	A356V	0	.	.	1066	1068	GCC	1232	1234	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:A356V:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	A357S	0	.	.	1069	1071	GCC	1235	1237	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:A357S:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	E368A	0	.	.	1102	1104	GAG	1268	1270	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:E368A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	P375A	0	.	.	1123	1125	CCG	1289	1291	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:P375A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	E378A	0	.	.	1132	1134	GAG	1298	1300	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:E378A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	S380R	0	.	.	1138	1140	AGC	1304	1306	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:S380R:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	P397Q	0	.	.	1189	1191	CCG	1355	1357	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:P397Q:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	N399H	0	.	.	1195	1197	AAC	1361	1363	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:N399H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	G406S	0	.	.	1216	1218	GGC	1382	1384	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G406S:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	G406C	0	.	.	1216	1218	GGC	1382	1384	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G406C:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	G406A	0	.	.	1216	1218	GGC	1382	1384	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G406A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	G406D	0	.	.	1216	1218	GGC	1382	1384	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G406D:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	L413P	0	.	.	1237	1239	CTG	1403	1405	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:L413P:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	P446H	0	.	.	1336	1338	CCC	1502	1504	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:P446H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	R460C	0	.	.	1378	1380	CGC	1544	1546	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:R460C:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	I465D	0	.	.	1393	1395	ATC	1559	1561	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:I465D:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	R469P	0	.	.	1405	1407	CGT	1571	1573	CGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:R469P:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	R471P	0	.	.	1411	1413	CGC	1577	1579	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:R471P:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	Q497R	0	.	.	1489	1491	CAG	1655	1657	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Q497R:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	Q497K	0	.	.	1489	1491	CAG	1655	1657	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Q497K:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	E504Q	0	.	.	1510	1512	GAA	1676	1678	GAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:E504Q:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	R507G	0	.	.	1519	1521	AGG	1685	1687	AGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:R507G:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	G745D	0	.	.	2233	2235	GGC	2399	2401	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G745D:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	D959A	0	.	.	2875	2877	GAC	3041	3043	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D959A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	M1000R	0	.	.	2998	3000	ATG	3164	3166	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M1000R:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1700	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3592	0.0	1	SNP	p	D1024N	0	.	.	3070	3072	GAC	3236	3238	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D1024N:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1636	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3787	0.0	1	SNP	p	R738Q	1	R738Q	NONSYN	2212	2214	CGG	2493	2495	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:R738Q:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1636	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3787	0.0	1	SNP	p	A247P	0	.	.	739	741	GCG	1020	1022	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:A247P:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1636	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3787	0.0	1	SNP	p	L251R	0	.	.	751	753	CTG	1032	1034	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:L251R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1636	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3787	0.0	1	SNP	p	A254G	0	.	.	760	762	GCC	1041	1043	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:A254G:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1636	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3787	0.0	1	SNP	p	T270I	0	.	.	808	810	ACC	1089	1091	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:T270I:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1636	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3787	0.0	1	SNP	p	H285Y	0	.	.	853	855	CAT	1134	1136	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:H285Y:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1636	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3787	0.0	1	SNP	p	V287F	0	.	.	859	861	GTC	1140	1142	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:V287F:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1636	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3787	0.0	1	SNP	p	G288W	0	.	.	862	864	GGG	1143	1145	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G288W:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1636	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3787	0.0	1	SNP	p	G288V	0	.	.	862	864	GGG	1143	1145	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G288V:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1636	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3787	0.0	1	SNP	p	Y296H	0	.	.	886	888	TAC	1167	1169	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y296H:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1636	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3787	0.0	1	SNP	p	Y296S	0	.	.	886	888	TAC	1167	1169	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y296S:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1636	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3787	0.0	1	SNP	p	I297L	0	.	.	889	891	ATC	1170	1172	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:I297L:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1636	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3787	0.0	1	SNP	p	I297T	0	.	.	889	891	ATC	1170	1172	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:I297T:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1636	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3787	0.0	1	SNP	p	M300R	0	.	.	898	900	ATG	1179	1181	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:M300R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1636	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3787	0.0	1	SNP	p	R302G	0	.	.	904	906	CGG	1185	1187	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:R302G:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1636	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3787	0.0	1	SNP	p	V303G	0	.	.	907	909	GTG	1188	1190	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:V303G:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1636	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3787	0.0	1	SNP	p	A307T	0	.	.	919	921	GCG	1200	1202	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:A307T:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1636	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3787	0.0	1	SNP	p	G308D	0	.	.	922	924	GGC	1203	1205	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G308D:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1636	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3787	0.0	1	SNP	p	Y309N	0	.	.	925	927	TAT	1206	1208	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y309N:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1636	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3787	0.0	1	SNP	p	M310K	0	.	.	928	930	ATG	1209	1211	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:M310K:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1636	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3787	0.0	1	SNP	p	G325S	0	.	.	973	975	GGC	1254	1256	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G325S:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1636	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3787	0.0	1	SNP	p	W326R	0	.	.	976	978	TGG	1257	1259	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:W326R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1636	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3787	0.0	1	SNP	p	Y327N	0	.	.	979	981	TAC	1260	1262	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y327N:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1636	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3787	0.0	1	SNP	p	N394D	0	.	.	1180	1182	AAC	1461	1463	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:N394D:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1636	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3787	0.0	1	SNP	p	P398S	0	.	.	1192	1194	CCC	1473	1475	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:P398S:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1636	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3787	0.0	1	SNP	p	Q491R	0	.	.	1471	1473	CAG	1752	1754	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Q491R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1636	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3787	0.0	1	SNP	p	L502P	0	.	.	1504	1506	CTC	1785	1787	CTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:L502P:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1636	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3787	0.0	1	SNP	p	V981L	0	.	.	2941	2943	GTG	3222	3224	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:V981L:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embR.3003455.AL123456.3.1416180_1417347.4712	embR.3003455.AL123456.3.1416180_1417347.4712	1	1	27	780	embR	1167	1167	100.0	embR.l15.c4.ctg.1	1530	0.0	1	SNP	p	C110Y	0	.	.	328	330	TGC	541	543	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embR.3003455.AL123456.3.1416180_1417347.4712:1:1:C110Y:.:b'Point mutation in the M.tuberculosis embR results in increased resistance to ethambutol.'	Mycobacterium tuberculosis embR mutant conferring resistance to ethambutol
embR.3003455.AL123456.3.1416180_1417347.4712	embR.3003455.AL123456.3.1416180_1417347.4712	1	1	27	780	embR	1167	1167	100.0	embR.l15.c4.ctg.1	1530	0.0	1	SNP	p	Q379R	0	.	.	1135	1137	CAG	1348	1350	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embR.3003455.AL123456.3.1416180_1417347.4712:1:1:Q379R:.:b'Point mutation in the M.tuberculosis embR results in increased resistance to ethambutol.'	Mycobacterium tuberculosis embR mutant conferring resistance to ethambutol
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	924	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1930	0.0	1	SNP	p	P28S	0	.	.	82	84	CCG	217	219	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:P28S:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	924	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1930	0.0	1	SNP	p	L35R	0	.	.	103	105	CTG	238	240	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:L35R:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	924	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1930	0.0	1	SNP	p	G42D	0	.	.	124	126	GGC	259	261	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:G42D:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	924	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1930	0.0	1	SNP	p	D56Y	0	.	.	166	168	GAC	301	303	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:D56Y:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	924	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1930	0.0	1	SNP	p	D58G	0	.	.	172	174	GAC	307	309	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:D58G:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	924	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1930	0.0	1	SNP	p	W69C	0	.	.	205	207	TGG	340	342	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:W69C:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	924	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1930	0.0	1	SNP	p	H102P	0	.	.	304	306	CAC	439	441	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:H102P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	924	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1930	0.0	1	SNP	p	Y141N	0	.	.	421	423	TAC	556	558	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:Y141N:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	924	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1930	0.0	1	SNP	p	V179F	0	.	.	535	537	GTC	670	672	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:V179F:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	924	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1930	0.0	1	SNP	p	T186P	0	.	.	556	558	ACG	691	693	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:T186P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	924	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1930	0.0	1	SNP	p	T189R	0	.	.	565	567	ACG	700	702	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:T189R:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	924	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1930	0.0	1	SNP	p	Q246P	0	.	.	736	738	CAG	871	873	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:Q246P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	924	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1930	0.0	1	SNP	p	Q254P	0	.	.	760	762	CAG	895	897	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:Q254P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	924	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1930	0.0	1	SNP	p	L267V	0	.	.	799	801	CTG	934	936	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:L267V:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	924	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1930	0.0	1	SNP	p	S329P	0	.	.	985	987	TCA	1120	1122	TCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:S329P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	924	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1930	0.0	1	SNP	p	A341V	0	.	.	1021	1023	GCA	1156	1158	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:A341V:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	924	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1930	0.0	1	SNP	p	N345K	0	.	.	1033	1035	AAC	1168	1170	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:N345K:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	924	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1930	0.0	1	SNP	p	A352E	0	.	.	1054	1056	GCG	1189	1191	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:A352E:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	924	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1930	0.0	1	SNP	p	M372R	0	.	.	1114	1116	ATG	1249	1251	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:M372R:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	924	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1930	0.0	1	SNP	p	A395D	0	.	.	1183	1185	GCC	1318	1320	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:A395D:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	924	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1930	0.0	1	SNP	p	C403Y	0	.	.	1207	1209	TGT	1342	1344	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:C403Y:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	924	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	1930	0.0	1	SNP	p	F480S	0	.	.	1438	1440	TTC	1573	1575	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:F480S:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	662	folC	1464	1464	100.0	folC.l6.c4.ctg.1	1969	0.0	1	SNP	p	T20P	0	.	.	58	60	ACT	320	322	ACT	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:T20P:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	662	folC	1464	1464	100.0	folC.l6.c4.ctg.1	1969	0.0	1	SNP	p	E40G	0	.	.	118	120	GAG	380	382	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E40G:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	662	folC	1464	1464	100.0	folC.l6.c4.ctg.1	1969	0.0	1	SNP	p	E40Q	0	.	.	118	120	GAG	380	382	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E40Q:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	662	folC	1464	1464	100.0	folC.l6.c4.ctg.1	1969	0.0	1	SNP	p	I43S	0	.	.	127	129	ATC	389	391	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:I43S:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	662	folC	1464	1464	100.0	folC.l6.c4.ctg.1	1969	0.0	1	SNP	p	I43T	0	.	.	127	129	ATC	389	391	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:I43T:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	662	folC	1464	1464	100.0	folC.l6.c4.ctg.1	1969	0.0	1	SNP	p	I43A	0	.	.	127	129	ATC	389	391	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:I43A:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	662	folC	1464	1464	100.0	folC.l6.c4.ctg.1	1969	0.0	1	SNP	p	R49P	0	.	.	145	147	CGG	407	409	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:R49P:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	662	folC	1464	1464	100.0	folC.l6.c4.ctg.1	1969	0.0	1	SNP	p	R49W	0	.	.	145	147	CGG	407	409	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:R49W:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	662	folC	1464	1464	100.0	folC.l6.c4.ctg.1	1969	0.0	1	SNP	p	L56V	0	.	.	166	168	CTG	428	430	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:L56V:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	662	folC	1464	1464	100.0	folC.l6.c4.ctg.1	1969	0.0	1	SNP	p	R91W	0	.	.	271	273	CGG	533	535	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:R91W:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	662	folC	1464	1464	100.0	folC.l6.c4.ctg.1	1969	0.0	1	SNP	p	S150G	0	.	.	448	450	AGC	710	712	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:S150G:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	662	folC	1464	1464	100.0	folC.l6.c4.ctg.1	1969	0.0	1	SNP	p	S150C	0	.	.	448	450	AGC	710	712	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:S150C:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	662	folC	1464	1464	100.0	folC.l6.c4.ctg.1	1969	0.0	1	SNP	p	E153G	0	.	.	457	459	GAG	719	721	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E153G:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	662	folC	1464	1464	100.0	folC.l6.c4.ctg.1	1969	0.0	1	SNP	p	E153A	0	.	.	457	459	GAG	719	721	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E153A:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	662	folC	1464	1464	100.0	folC.l6.c4.ctg.1	1969	0.0	1	SNP	p	A420V	0	.	.	1258	1260	GCG	1520	1522	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:A420V:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	428	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1175	0.0	1	SNP	p	G30R	0	.	.	88	90	GGT	381	383	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G30R:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	428	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1175	0.0	1	SNP	p	G37V	0	.	.	109	111	GGA	402	404	GGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G37V:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	428	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1175	0.0	1	SNP	p	W45C	0	.	.	133	135	TGG	426	428	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:W45C:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	428	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1175	0.0	1	SNP	p	W45S	0	.	.	133	135	TGG	426	428	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:W45S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	428	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1175	0.0	1	SNP	p	R47Q	0	.	.	139	141	CGG	432	434	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:R47Q:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	428	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1175	0.0	1	SNP	p	H48Y	0	.	.	142	144	CAT	435	437	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:H48Y:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	428	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1175	0.0	1	SNP	p	L49F	0	.	.	145	147	CTA	438	440	CTA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:L49F:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	428	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1175	0.0	1	SNP	p	I55S	0	.	.	163	165	ATC	456	458	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:I55S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	428	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1175	0.0	1	SNP	p	D67H	0	.	.	199	201	GAT	492	494	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:D67H:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	428	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1175	0.0	1	SNP	p	S70R	0	.	.	208	210	AGC	501	503	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:S70R:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	428	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1175	0.0	1	SNP	p	G71V	0	.	.	211	213	GGA	504	506	GGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G71V:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	428	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1175	0.0	1	SNP	p	P75S	0	.	.	223	225	CCG	516	518	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:P75S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	428	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1175	0.0	1	SNP	p	L79S	0	.	.	235	237	TTG	528	530	TTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:L79S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	428	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1175	0.0	1	SNP	p	L79F	0	.	.	235	237	TTG	528	530	TTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:L79F:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	428	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1175	0.0	1	SNP	p	P84L	0	.	.	250	252	CCG	543	545	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:P84L:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	428	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1175	0.0	1	SNP	p	P84C	0	.	.	250	252	CCG	543	545	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:P84C:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	428	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1175	0.0	1	SNP	p	E92A	0	.	.	274	276	GAA	567	569	GAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:E92A:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	428	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1175	0.0	1	SNP	p	G117E	0	.	.	349	351	GGG	642	644	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G117E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	428	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1175	0.0	1	SNP	p	V124G	0	.	.	370	372	GTG	663	665	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:V124G:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	428	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1175	0.0	1	SNP	p	Q127P	0	.	.	379	381	CAA	672	674	CAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:Q127P:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	428	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1175	0.0	1	SNP	p	A134E	0	.	.	400	402	GCG	693	695	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A134E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	428	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1175	0.0	1	SNP	p	A138E	0	.	.	412	414	GCG	705	707	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A138E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	428	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1175	0.0	1	SNP	p	V139A	0	.	.	415	417	GTG	708	710	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:V139A:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	428	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1175	0.0	1	SNP	p	W148R	0	.	.	442	444	TGG	735	737	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:W148R:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	428	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1175	0.0	1	SNP	p	G164C	0	.	.	490	492	GGC	783	785	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G164C:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	428	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1175	0.0	1	SNP	p	A183E	0	.	.	547	549	GCG	840	842	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A183E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	428	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1175	0.0	1	SNP	p	A183T	0	.	.	547	549	GCG	840	842	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A183T:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	428	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1175	0.0	1	SNP	p	V188G	0	.	.	562	564	GTG	855	857	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:V188G:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	428	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1175	0.0	1	SNP	p	V188M	0	.	.	562	564	GTG	855	857	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:V188M:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	428	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1175	0.0	1	SNP	p	A200E	0	.	.	598	600	GCG	891	893	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A200E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1574	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2995	0.0	0	.	p	.	0	E21Q	NONSYN	61	63	GAG	290	292	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1574	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2995	0.0	0	.	p	.	0	S95T	NONSYN	283	285	AGC	512	514	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1574	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2995	0.0	0	.	p	.	0	G668D	NONSYN	2002	2004	GGC	2231	2233	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1574	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2995	0.0	1	SNP	p	A74S	0	.	.	220	222	GCC	449	451	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:A74S:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1574	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2995	0.0	1	SNP	p	T80A	0	.	.	238	240	ACC	467	469	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:T80A:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1574	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2995	0.0	1	SNP	p	G88C	0	.	.	262	264	GGC	491	493	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:G88C:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1574	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2995	0.0	1	SNP	p	G88A	0	.	.	262	264	GGC	491	493	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:G88A:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1574	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2995	0.0	1	SNP	p	D89V	0	.	.	265	267	GAC	494	496	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D89V:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1574	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2995	0.0	1	SNP	p	D89N	0	.	.	265	267	GAC	494	496	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D89N:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1574	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2995	0.0	1	SNP	p	D89G	0	.	.	265	267	GAC	494	496	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D89G:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1574	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2995	0.0	1	SNP	p	A90G	0	.	.	268	270	GCG	497	499	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:A90G:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1574	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2995	0.0	1	SNP	p	A90V	0	.	.	268	270	GCG	497	499	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:A90V:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1574	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2995	0.0	1	SNP	p	S91P	0	.	.	271	273	TCG	500	502	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:S91P:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1574	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2995	0.0	1	SNP	p	D94A	0	.	.	280	282	GAC	509	511	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94A:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1574	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2995	0.0	1	SNP	p	D94V	0	.	.	280	282	GAC	509	511	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94V:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1574	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2995	0.0	1	SNP	p	D94N	0	.	.	280	282	GAC	509	511	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94N:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1574	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2995	0.0	1	SNP	p	D94Y	0	.	.	280	282	GAC	509	511	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94Y:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1574	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2995	0.0	1	SNP	p	D94T	0	.	.	280	282	GAC	509	511	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94T:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1574	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2995	0.0	1	SNP	p	D94G	0	.	.	280	282	GAC	509	511	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94G:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1574	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	2995	0.0	1	SNP	p	P102H	0	.	.	304	306	CCC	533	535	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:P102H:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1418	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	2712	0.0	1	SNP	p	V340L	0	.	.	1018	1020	GTG	1356	1358	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:V340L:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1418	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	2712	0.0	1	SNP	p	D500H	0	.	.	1498	1500	GAC	1836	1838	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:D500H:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1418	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	2712	0.0	1	SNP	p	N538K	0	.	.	1612	1614	AAC	1950	1952	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:N538K:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1418	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	2712	0.0	1	SNP	p	N538D	0	.	.	1612	1614	AAC	1950	1952	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:N538D:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1418	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	2712	0.0	1	SNP	p	T539P	0	.	.	1615	1617	ACC	1953	1955	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:T539P:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1418	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	2712	0.0	1	SNP	p	T539N	0	.	.	1615	1617	ACC	1953	1955	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:T539N:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1418	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	2712	0.0	1	SNP	p	E540V	0	.	.	1618	1620	GAA	1956	1958	GAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:E540V:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1418	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	2712	0.0	1	SNP	p	E540D	0	.	.	1618	1620	GAA	1956	1958	GAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:E540D:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	412	inhA	810	810	100.0	inhA.l6.c4.ctg.1	1209	0.0	1	SNP	p	I16T	0	.	.	46	48	ATC	244	246	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I16T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	412	inhA	810	810	100.0	inhA.l6.c4.ctg.1	1209	0.0	1	SNP	p	I21T	0	.	.	61	63	ATC	259	261	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I21T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	412	inhA	810	810	100.0	inhA.l6.c4.ctg.1	1209	0.0	1	SNP	p	I21V	0	.	.	61	63	ATC	259	261	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I21V:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	412	inhA	810	810	100.0	inhA.l6.c4.ctg.1	1209	0.0	1	SNP	p	I47T	0	.	.	139	141	ATT	337	339	ATT	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I47T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	412	inhA	810	810	100.0	inhA.l6.c4.ctg.1	1209	0.0	1	SNP	p	V78A	0	.	.	232	234	GTG	430	432	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:V78A:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	412	inhA	810	810	100.0	inhA.l6.c4.ctg.1	1209	0.0	1	SNP	p	S94A	0	.	.	280	282	TCG	478	480	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:S94A:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	412	inhA	810	810	100.0	inhA.l6.c4.ctg.1	1209	0.0	1	SNP	p	I95P	0	.	.	283	285	ATT	481	483	ATT	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I95P:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	412	inhA	810	810	100.0	inhA.l6.c4.ctg.1	1209	0.0	1	SNP	p	G141E	0	.	.	421	423	GGA	619	621	GGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:G141E:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	412	inhA	810	810	100.0	inhA.l6.c4.ctg.1	1209	0.0	1	SNP	p	I194T	0	.	.	580	582	ATC	778	780	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I194T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	27	1136	iniA	1923	1923	100.0	iniA.l15.c4.ctg.1	2363	0.0	1	SNP	p	P3A	0	.	.	7	9	CCC	193	195	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:P3A:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	27	1136	iniA	1923	1923	100.0	iniA.l15.c4.ctg.1	2363	0.0	1	SNP	p	G308R	0	.	.	922	924	GGG	1108	1110	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:G308R:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	27	1136	iniA	1923	1923	100.0	iniA.l15.c4.ctg.1	2363	0.0	1	SNP	p	S501W	0	.	.	1501	1503	TCG	1687	1689	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:S501W:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	27	1136	iniA	1923	1923	100.0	iniA.l15.c4.ctg.1	2363	0.0	1	SNP	p	R537H	0	.	.	1609	1611	CGC	1795	1797	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:R537H:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniB.3004135.AL123456.3.409361_410801.5509	iniB.3004135.AL123456.3.409361_410801.5509	1	1	516	482	iniB	1440	1085	100.0	iniB.l6.c4.ctg.1	1434	0.0	1	SNP	p	A47T	0	.	.	139	141	GCC	488	490	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniB.3004135.AL123456.3.409361_410801.5509:1:1:A47T:.:b'Point mutations in M. tuberculosis iniB shown to confer resistance to ethambutol.'	Mycobacterium tuberculosis iniB with mutation conferring resistance to ethambutol
iniB.3004135.AL123456.3.409361_410801.5509	iniB.3004135.AL123456.3.409361_410801.5509	1	1	516	482	iniB	1440	172	100.0	iniB.l6.c4.ctg.2	534	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Mycobacterium tuberculosis iniB with mutation conferring resistance to ethambutol
iniB.3004135.AL123456.3.409361_410801.5509	iniB.3004135.AL123456.3.409361_410801.5509	1	1	516	482	iniB	1440	156	93.59	iniB.l6.c4.ctg.3	396	0.0	0	.	p	.	0	D86A	NONSYN	256	258	GAC	242	244	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis iniB with mutation conferring resistance to ethambutol
iniB.3004135.AL123456.3.409361_410801.5509	iniB.3004135.AL123456.3.409361_410801.5509	1	1	516	482	iniB	1440	156	93.59	iniB.l6.c4.ctg.3	396	0.0	0	.	p	.	0	L117R	NONSYN	349	351	CTG	335	337	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis iniB with mutation conferring resistance to ethambutol
iniB.3004135.AL123456.3.409361_410801.5509	iniB.3004135.AL123456.3.409361_410801.5509	1	1	516	482	iniB	1440	156	93.59	iniB.l6.c4.ctg.3	396	0.0	0	.	p	.	0	S122trunc	TRUNC	364	364	T	350	350	T	ND	ND	ND	.	Mycobacterium tuberculosis iniB with mutation conferring resistance to ethambutol
iniB.3004135.AL123456.3.409361_410801.5509	iniB.3004135.AL123456.3.409361_410801.5509	1	1	516	482	iniB	1440	156	93.59	iniB.l6.c4.ctg.3	396	0.0	0	.	p	.	0	S123R	NONSYN	367	369	AGC	353	355	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis iniB with mutation conferring resistance to ethambutol
iniB.3004135.AL123456.3.409361_410801.5509	iniB.3004135.AL123456.3.409361_410801.5509	1	1	516	482	iniB	1440	156	93.59	iniB.l6.c4.ctg.3	396	0.0	0	.	p	.	0	F126V	NONSYN	376	378	TTC	362	364	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis iniB with mutation conferring resistance to ethambutol
iniC.3003451.AL123456.1.412756_414238.2100	iniC.3003451.AL123456.1.412756_414238.2100	1	1	27	834	iniC	1482	1482	100.0	iniC.l15.c4.ctg.1	2178	0.0	1	SNP	p	W83G	0	.	.	247	249	TGG	596	598	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniC.3003451.AL123456.1.412756_414238.2100:1:1:W83G:.:b'Specific mutations that occurs on Mycobacterium tuberculosis iniC causing it to be ethambutol resistant.'	Mycobacterium tuberculosis iniC mutant conferring resistance to ethambutol
iniC.3003451.AL123456.1.412756_414238.2100	iniC.3003451.AL123456.1.412756_414238.2100	1	1	27	834	iniC	1482	1482	100.0	iniC.l15.c4.ctg.1	2178	0.0	1	SNP	p	P248A	0	.	.	742	744	CCG	1091	1093	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniC.3003451.AL123456.1.412756_414238.2100:1:1:P248A:.:b'Specific mutations that occurs on Mycobacterium tuberculosis iniC causing it to be ethambutol resistant.'	Mycobacterium tuberculosis iniC mutant conferring resistance to ethambutol
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	468	kasA	1251	1251	100.0	kasA.l15.c4.ctg.1	1674	0.0	1	SNP	p	D66N	0	.	.	196	198	GAT	415	417	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:D66N:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	468	kasA	1251	1251	100.0	kasA.l15.c4.ctg.1	1674	0.0	1	SNP	p	R121K	0	.	.	361	363	AGG	580	582	AGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:R121K:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	468	kasA	1251	1251	100.0	kasA.l15.c4.ctg.1	1674	0.0	1	SNP	p	G269S	0	.	.	805	807	GGT	1024	1026	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:G269S:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	468	kasA	1251	1251	100.0	kasA.l15.c4.ctg.1	1674	0.0	1	SNP	p	G312S	0	.	.	934	936	GGC	1153	1155	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:G312S:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	468	kasA	1251	1251	100.0	kasA.l15.c4.ctg.1	1674	0.0	1	SNP	p	G387D	0	.	.	1159	1161	GGC	1378	1380	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:G387D:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	468	kasA	1251	1251	100.0	kasA.l15.c4.ctg.1	1674	0.0	1	SNP	p	F413L	0	.	.	1237	1239	TTC	1456	1458	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:F413L:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1292	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2771	0.0	0	.	p	.	0	R463L	NONSYN	1387	1389	CGG	1749	1751	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1292	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2771	0.0	1	SNP	p	G33V	0	.	.	97	99	GGC	459	461	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G33V:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1292	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2771	0.0	1	SNP	p	W91R	0	.	.	271	273	TGG	633	635	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:W91R:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1292	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2771	0.0	1	SNP	p	A110V	0	.	.	328	330	GCC	690	692	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:A110V:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1292	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2771	0.0	1	SNP	p	G111S	0	.	.	331	333	GGC	693	695	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G111S:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1292	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2771	0.0	1	SNP	p	G125S	0	.	.	373	375	GGC	735	737	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G125S:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1292	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2771	0.0	1	SNP	p	M126I	0	.	.	376	378	ATG	738	740	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:M126I:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1292	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2771	0.0	1	SNP	p	Q127P	0	.	.	379	381	CAG	741	743	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:Q127P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1292	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2771	0.0	1	SNP	p	D142G	0	.	.	424	426	GAC	786	788	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:D142G:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1292	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2771	0.0	1	SNP	p	L147P	0	.	.	439	441	CTG	801	803	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:L147P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1292	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2771	0.0	1	SNP	p	A264V	0	.	.	790	792	GCG	1152	1154	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:A264V:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1292	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2771	0.0	1	SNP	p	A312P	0	.	.	934	936	GCG	1296	1298	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:A312P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1292	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2771	0.0	1	SNP	p	S315T	0	.	.	943	945	AGC	1305	1307	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:S315T:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1292	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2771	0.0	1	SNP	p	S315N	0	.	.	943	945	AGC	1305	1307	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:S315N:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1292	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2771	0.0	1	SNP	p	S315G	0	.	.	943	945	AGC	1305	1307	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:S315G:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1292	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2771	0.0	1	SNP	p	H417Q	0	.	.	1249	1251	CAC	1611	1613	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:H417Q:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1292	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2771	0.0	1	SNP	p	Q461P	0	.	.	1381	1383	CAG	1743	1745	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:Q461P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1292	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2771	0.0	1	SNP	p	G490S	0	.	.	1468	1470	GGC	1830	1832	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G490S:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1292	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2771	0.0	1	SNP	p	N508D	0	.	.	1522	1524	AAC	1884	1886	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:N508D:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1292	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2771	0.0	1	SNP	p	E607A	0	.	.	1819	1821	GAG	2181	2183	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:E607A:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1292	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2771	0.0	1	SNP	p	N660D	0	.	.	1978	1980	AAC	2340	2342	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:N660D:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
mfpA.3003035.AL123456.1.3773015_3773567.4588	mfpA.3003035.AL123456.1.3773015_3773567.4588	1	0	27	418	mfpA	552	552	100.0	mfpA.l15.c4.ctg.1	886	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	b'mfpA is a qnr homolog and a pentapeptide repeat protein that confers resistance to fluoroquinolones in Mycolicibacterium smegmatis.';mfpA
mshA.3005108.NC_000962.3.575347_576790.6150	mshA.3005108.NC_000962.3.575347_576790.6150	1	1	27	582	mshA_1	1443	1443	100.0	mshA_1.l15.c4.ctg.1	1816	0.0	1	SNP	p	F355S	0	.	.	1063	1065	TTC	1234	1236	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	mshA.3005108.NC_000962.3.575347_576790.6150:1:1:F355S:.:b'Mutations in Mycobacterium tuberculosis mshA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis mshA mutations conferring resistance to prothionamide
murA.3003784.HE608151.1.1472985_1474242.3555	murA.3003784.HE608151.1.1472985_1474242.3555	1	1	539	776	murA_4	1257	1257	99.92	murA_4.l6.c30.ctg.1	1885	0.0	0	.	p	.	0	Q205H	NONSYN	613	615	CAG	841	843	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis intrinsic murA conferring resistance to fosfomycin
murA.3003784.HE608151.1.1472985_1474242.3555	murA.3003784.HE608151.1.1472985_1474242.3555	1	1	539	776	murA_4	1257	1257	99.92	murA_4.l6.c30.ctg.1	1885	0.0	1	SNP	p	C117D	1	.	.	349	351	GAC	577	579	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	murA.3003784.HE608151.1.1472985_1474242.3555:1:1:C117D:.:b'Mycobacterium tuberculosis murA confers intrinsic resistance to fosfomycin. The presence of an aspartic acid residue in place of the critical cysteine at position 117 that enables fosfomycin binding is believed to be responsible for this intrinsic resistance.'	Mycobacterium tuberculosis intrinsic murA conferring resistance to fosfomycin
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	M1S	0	.	.	1	3	ATG	165	167	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:M1S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	A3E	0	.	.	7	9	GCG	171	173	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A3E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	L4W	0	.	.	10	12	TTG	174	176	TTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L4W:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	I5S	0	.	.	13	15	ATC	177	179	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:I5S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	V7D	0	.	.	19	21	GTC	183	185	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V7D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	V7F	0	.	.	19	21	GTC	183	185	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V7F:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	V7G	0	.	.	19	21	GTC	183	185	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V7G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	D8Y	0	.	.	22	24	GAC	186	188	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D8Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	V9A	0	.	.	25	27	GTG	189	191	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V9A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	V9G	0	.	.	25	27	GTG	189	191	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V9G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	Q10K	0	.	.	28	30	CAG	192	194	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q10K:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	Q10P	0	.	.	28	30	CAG	192	194	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q10P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	Q10R	0	.	.	28	30	CAG	192	194	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q10R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	D12E	0	.	.	34	36	GAC	198	200	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D12E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	D12N	0	.	.	34	36	GAC	198	200	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D12N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	D12A	0	.	.	34	36	GAC	198	200	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D12A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	C14Y	0	.	.	40	42	TGC	204	206	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C14Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	C14R	0	.	.	40	42	TGC	204	206	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C14R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	G17D	0	.	.	49	51	GGC	213	215	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G17D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	G17S	0	.	.	49	51	GGC	213	215	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G17S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	L19P	0	.	.	55	57	CTG	219	221	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L19P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	G23V	0	.	.	67	69	GGT	231	233	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G23V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	A26G	0	.	.	76	78	GCG	240	242	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A26G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	L27P	0	.	.	79	81	CTG	243	245	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L27P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	Y34S	0	.	.	100	102	TAC	264	266	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y34S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	Y41H	0	.	.	121	123	TAC	285	287	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y41H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	V45G	0	.	.	133	135	GTG	297	299	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V45G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	A46V	0	.	.	136	138	GCA	300	302	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A46V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	A46E	0	.	.	136	138	GCA	300	302	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A46E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	T47P	0	.	.	139	141	ACC	303	305	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T47P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	T47S	0	.	.	139	141	ACC	303	305	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T47S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	T47A	0	.	.	139	141	ACC	303	305	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T47A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	D49V	0	.	.	145	147	GAC	309	311	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D49V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	D49A	0	.	.	145	147	GAC	309	311	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D49A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	H51Q	0	.	.	151	153	CAC	315	317	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H51Q:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	H51Y	0	.	.	151	153	CAC	315	317	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H51Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	D53A	0	.	.	157	159	GAC	321	323	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D53A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	P54T	0	.	.	160	162	CCG	324	326	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P54T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	P54L	0	.	.	160	162	CCG	324	326	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P54L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	H57D	0	.	.	169	171	CAC	333	335	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H57D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	H57Q	0	.	.	169	171	CAC	333	335	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H57Q:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	F58L	0	.	.	172	174	TTC	336	338	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:F58L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	P62H	0	.	.	184	186	CCG	348	350	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P62H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	S66P	0	.	.	196	198	TCG	360	362	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S66P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	S67P	0	.	.	199	201	TCG	363	365	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S67P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	W68G	0	.	.	202	204	TGG	366	368	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	W68R	0	.	.	202	204	TGG	366	368	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	W68C	0	.	.	202	204	TGG	366	368	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68C:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	W68L	0	.	.	202	204	TGG	366	368	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	W68S	0	.	.	202	204	TGG	366	368	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	P69R	0	.	.	205	207	CCA	369	371	CCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P69R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	H71E	0	.	.	211	213	CAT	375	377	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H71E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	C72W	0	.	.	214	216	TGC	378	380	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C72W:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	C72R	0	.	.	214	216	TGC	378	380	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C72R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	T76I	0	.	.	226	228	ACT	390	392	ACT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T76I:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	T76P	0	.	.	226	228	ACT	390	392	ACT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T76P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	G78D	0	.	.	232	234	GGC	396	398	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G78D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	H82R	0	.	.	244	246	CAT	408	410	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H82R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	L85P	0	.	.	253	255	CTG	417	419	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L85P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	L85R	0	.	.	253	255	CTG	417	419	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L85R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	I90S	0	.	.	268	270	ATC	432	434	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:I90S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	F94P	0	.	.	280	282	TTC	444	446	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:F94P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	K96E	0	.	.	286	288	AAG	450	452	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	K96N	0	.	.	286	288	AAG	450	452	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	K96Q	0	.	.	286	288	AAG	450	452	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96Q:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	K96M	0	.	.	286	288	AAG	450	452	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96M:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	G97S	0	.	.	289	291	GGT	453	455	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G97S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	T100P	0	.	.	298	300	ACC	462	464	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T100P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	A102V	0	.	.	304	306	GCG	468	470	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A102V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	A102T	0	.	.	304	306	GCG	468	470	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A102T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	Y103S	0	.	.	307	309	TAC	471	473	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y103S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	Y103H	0	.	.	307	309	TAC	471	473	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y103H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	S104C	0	.	.	310	312	AGC	474	476	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S104C:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	L116R	0	.	.	346	348	CTG	510	512	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L116R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	N118T	0	.	.	352	354	AAT	516	518	AAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:N118T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	W119R	0	.	.	355	357	TGG	519	521	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W119R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	R121P	0	.	.	361	363	CGG	525	527	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:R121P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	V125D	0	.	.	373	375	GTC	537	539	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V125D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	G132S	0	.	.	394	396	GGT	558	560	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G132S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	I133T	0	.	.	397	399	ATT	561	563	ATT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:I133T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	A134V	0	.	.	400	402	GCC	564	566	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A134V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	T135P	0	.	.	403	405	ACC	567	569	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T135P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	D136H	0	.	.	406	408	GAT	570	572	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D136H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	D136Y	0	.	.	406	408	GAT	570	572	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D136Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	D136N	0	.	.	406	408	GAT	570	572	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D136N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	H137R	0	.	.	409	411	CAT	573	575	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H137R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	H137P	0	.	.	409	411	CAT	573	575	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H137P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	C138Y	0	.	.	412	414	TGT	576	578	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C138Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	C138W	0	.	.	412	414	TGT	576	578	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C138W:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	C138S	0	.	.	412	414	TGT	576	578	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C138S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	V139A	0	.	.	415	417	GTG	579	581	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V139A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	V139L	0	.	.	415	417	GTG	579	581	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V139L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	V139M	0	.	.	415	417	GTG	579	581	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V139M:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	R140G	0	.	.	418	420	CGC	582	584	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:R140G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	Q141P	0	.	.	421	423	CAG	585	587	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q141P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	T142K	0	.	.	424	426	ACG	588	590	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T142K:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	T142M	0	.	.	424	426	ACG	588	590	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T142M:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	A146T	0	.	.	436	438	GCG	600	602	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A146T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	R154G	0	.	.	460	462	AGG	624	626	AGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:R154G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	V155G	0	.	.	463	465	GTG	627	629	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V155G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	V157G	0	.	.	469	471	GTG	633	635	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V157G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	L159R	0	.	.	475	477	CTG	639	641	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L159R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	T160P	0	.	.	478	480	ACA	642	644	ACA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T160P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	A161P	0	.	.	481	483	GCG	645	647	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A161P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	A161G	0	.	.	481	483	GCG	645	647	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A161G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	S164P	0	.	.	490	492	TCG	654	656	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S164P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	T168N	0	.	.	502	504	ACC	666	668	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T168N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	A171V	0	.	.	511	513	GCG	675	677	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A171V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	A171P	0	.	.	511	513	GCG	675	677	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A171P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	A171T	0	.	.	511	513	GCG	675	677	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A171T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	L172A	0	.	.	514	516	CTG	678	680	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L172A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	L172P	0	.	.	514	516	CTG	678	680	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L172P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	E174G	0	.	.	520	522	GAG	684	686	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:E174G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	M175V	0	.	.	523	525	ATG	687	689	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:M175V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	V180F	0	.	.	538	540	GTC	702	704	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V180F:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	370	pncA	561	561	99.82	pncA.l6.c4.ctg.1	1046	0.0	1	SNP	p	L182S	0	.	.	544	546	TTG	708	710	TTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L182S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
ribD.3004184.AL123456.3.2986838_2987615.5511	ribD.3004184.AL123456.3.2986838_2987615.5511	1	1	27	442	ribD	777	777	100.0	ribD.l15.c4.ctg.1	1292	0.0	1	SNP	p	G8R	0	.	.	22	24	GGA	334	336	GGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	ribD.3004184.AL123456.3.2986838_2987615.5511:1:1:G8R:.:b'ribD is a Mycobacterium tuberculosis riboflavin biosynthesis enzyme. Point mutations in ribD cause enzyme overexpression, which allows the C-terminal reductase domain to act as an alternative dihydrofolate reductase. Thus, mutations in ribD confer resistance to DHFR inhibitors such as para-aminosalicylic acid.'	Mycobacterium tuberculosis ribD with mutation conferring resistance to para-aminosalicylic acid
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2016	rpoB_1	3519	3519	99.94	rpoB_1.l15.c30.ctg.1	3862	0.0	1	SNP	p	V146F	0	.	.	436	438	GTG	603	605	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:V146F:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2016	rpoB_1	3519	3519	99.94	rpoB_1.l15.c30.ctg.1	3862	0.0	1	SNP	p	S450L	0	.	.	1348	1350	TCG	1515	1517	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:S450L:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2016	rpoB_1	3519	3519	99.94	rpoB_1.l15.c30.ctg.1	3862	0.0	1	SNP	p	F505L	0	.	.	1513	1515	TTC	1680	1682	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:F505L:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2016	rpoB_1	3519	3519	99.94	rpoB_1.l15.c30.ctg.1	3862	0.0	1	SNP	p	T508H	0	.	.	1522	1524	ACG	1689	1691	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508H:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2016	rpoB_1	3519	3519	99.94	rpoB_1.l15.c30.ctg.1	3862	0.0	1	SNP	p	T508S	0	.	.	1522	1524	ACG	1689	1691	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508S:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2016	rpoB_1	3519	3519	99.94	rpoB_1.l15.c30.ctg.1	3862	0.0	1	SNP	p	T508P	0	.	.	1522	1524	ACG	1689	1691	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508P:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2016	rpoB_1	3519	3519	99.94	rpoB_1.l15.c30.ctg.1	3862	0.0	1	SNP	p	T508A	0	.	.	1522	1524	ACG	1689	1691	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508A:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2016	rpoB_1	3519	3519	99.94	rpoB_1.l15.c30.ctg.1	3862	0.0	1	SNP	p	T508N	0	.	.	1522	1524	ACG	1689	1691	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508N:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2016	rpoB_1	3519	3519	99.94	rpoB_1.l15.c30.ctg.1	3862	0.0	1	SNP	p	L511R	1	.	.	1531	1533	CGC	1698	1700	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:L511R:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2016	rpoB_1	3519	3519	99.94	rpoB_1.l15.c30.ctg.1	3862	0.0	1	SNP	p	D516G	1	.	.	1546	1548	GGC	1713	1715	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:D516G:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2016	rpoB_1	3519	3519	99.94	rpoB_1.l15.c30.ctg.1	3862	0.0	1	SNP	p	H526T	1	.	.	1576	1578	ACC	1743	1745	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:H526T:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	986	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	1957	0.0	1	SNP	p	D123A	0	.	.	367	369	GAC	603	605	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:D123A:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	986	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	1957	0.0	1	SNP	p	S324F	0	.	.	970	972	TCC	1206	1208	TCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:S324F:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	986	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	1957	0.0	1	SNP	p	E325K	0	.	.	973	975	GAG	1209	1211	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:E325K:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	986	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	1957	0.0	1	SNP	p	G341R	0	.	.	1021	1023	GGC	1257	1259	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:G341R:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	986	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	1957	0.0	1	SNP	p	D342N	0	.	.	1024	1026	GAC	1260	1262	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:D342N:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	986	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	1957	0.0	1	SNP	p	D343N	0	.	.	1027	1029	GAC	1263	1265	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:D343N:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	986	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	1957	0.0	1	SNP	p	A344P	0	.	.	1030	1032	GCG	1266	1268	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:A344P:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	986	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	1957	0.0	1	SNP	p	I351F	0	.	.	1051	1053	ATC	1287	1289	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:I351F:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	27	296	rpsL	375	375	100.0	rpsL.l6.c4.ctg.1	1104	0.0	1	SNP	p	T40I	0	.	.	118	120	ACC	537	539	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:T40I:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	27	296	rpsL	375	375	100.0	rpsL.l6.c4.ctg.1	1104	0.0	1	SNP	p	K43R	0	.	.	127	129	AAG	546	548	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:K43R:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	27	296	rpsL	375	375	100.0	rpsL.l6.c4.ctg.1	1104	0.0	1	SNP	p	K88Q	0	.	.	262	264	AAG	681	683	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:K88Q:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	27	296	rpsL	375	375	100.0	rpsL.l6.c4.ctg.1	1104	0.0	1	SNP	p	K88R	0	.	.	262	264	AAG	681	683	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:K88R:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	90	rrsB_9	1454	830	97.6	rrsB_9.l15.c30.ctg.1	856	0.0	0	.	n	.	0	C949.	DEL	949	949	C	324	324	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	90	rrsB_9	1454	830	97.6	rrsB_9.l15.c30.ctg.1	856	0.0	0	.	n	.	0	.953T	INS	953	953	C	329	329	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	90	rrsB_9	1454	830	97.6	rrsB_9.l15.c30.ctg.1	856	0.0	0	.	n	.	0	.959A	INS	959	959	T	336	336	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	90	rrsB_9	1454	830	97.6	rrsB_9.l15.c30.ctg.1	856	0.0	0	.	n	.	0	G963.	DEL	963	963	G	339	339	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	90	rrsB_9	1454	830	97.6	rrsB_9.l15.c30.ctg.1	856	0.0	0	.	n	.	0	T1076A	SNP	1076	1076	T	452	452	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	90	rrsB_9	1454	830	97.6	rrsB_9.l15.c30.ctg.1	856	0.0	0	.	n	.	0	T1207C	SNP	1207	1207	T	583	583	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	90	rrsB_9	1454	830	97.6	rrsB_9.l15.c30.ctg.1	856	0.0	0	.	n	.	0	G1214A	SNP	1214	1214	G	590	590	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	90	rrsB_9	1454	830	97.6	rrsB_9.l15.c30.ctg.1	856	0.0	0	.	n	.	0	T1224.	DEL	1224	1224	T	599	599	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	90	rrsB_9	1454	830	97.6	rrsB_9.l15.c30.ctg.1	856	0.0	0	.	n	.	0	C1227A	SNP	1227	1227	C	602	602	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	90	rrsB_9	1454	830	97.6	rrsB_9.l15.c30.ctg.1	856	0.0	0	.	n	.	0	G1380A	SNP	1380	1380	G	755	755	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	90	rrsB_9	1454	830	97.6	rrsB_9.l15.c30.ctg.1	856	0.0	0	.	n	.	0	T1394C	SNP	1394	1394	T	769	769	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	90	rrsB_9	1454	830	97.6	rrsB_9.l15.c30.ctg.1	856	0.0	0	.	n	.	0	T1396.	DEL	1396	1396	T	770	770	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	90	rrsB_9	1454	830	97.6	rrsB_9.l15.c30.ctg.1	856	0.0	0	.	n	.	0	C1406T	SNP	1406	1406	C	780	780	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	90	rrsB_9	1454	830	97.6	rrsB_9.l15.c30.ctg.1	856	0.0	1	SNP	n	C1439U	0	.	.	1439	1439	C	813	813	C	ND	ND	ND	rrsB.3003540.X52922.1.0_1454.4148:0:0:C1439U:.:b'Point mutations in the highly conserved helix 44 of the 16S rrsB rRNA gene of Mycolicibacterium smegmatis can confer resistance to hygromycin B. Resistance against hygromycin B is the result of conformational alterations that distorts a strong hydrogen bond leading to a change in the local geometry of the hygromycin B binding site.'	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	160	rrsB_13	1528	251	90.51	rrsB_13.l15.c4.ctg.1	626	0.0	0	.	n	.	0	C81T	SNP	81	81	C	455	455	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	160	rrsB_13	1528	251	90.51	rrsB_13.l15.c4.ctg.1	626	0.0	0	.	n	.	0	T82C	SNP	82	82	T	456	456	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	160	rrsB_13	1528	251	90.51	rrsB_13.l15.c4.ctg.1	626	0.0	0	.	n	.	0	G90A	SNP	90	90	G	464	464	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	160	rrsB_13	1528	251	90.51	rrsB_13.l15.c4.ctg.1	626	0.0	0	.	n	.	0	T142C	SNP	142	142	T	516	516	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	160	rrsB_13	1528	251	90.51	rrsB_13.l15.c4.ctg.1	626	0.0	0	.	n	.	0	A175G	SNP	175	175	A	549	549	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	160	rrsB_13	1528	251	90.51	rrsB_13.l15.c4.ctg.1	626	0.0	0	.	n	.	0	A180G	SNP	180	180	A	554	554	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	160	rrsB_13	1528	251	90.51	rrsB_13.l15.c4.ctg.1	626	0.0	0	.	n	.	0	C181A	SNP	181	181	C	555	555	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	160	rrsB_13	1528	251	90.51	rrsB_13.l15.c4.ctg.1	626	0.0	0	.	n	.	0	G185A	SNP	185	185	G	558	558	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	160	rrsB_13	1528	251	90.51	rrsB_13.l15.c4.ctg.1	626	0.0	0	.	n	.	0	T187G	SNP	187	187	T	560	560	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	160	rrsB_13	1528	251	90.51	rrsB_13.l15.c4.ctg.1	626	0.0	0	.	n	.	0	C191T	SNP	191	191	C	564	564	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	160	rrsB_13	1528	251	90.51	rrsB_13.l15.c4.ctg.1	626	0.0	0	.	n	.	0	C198T	SNP	198	198	C	570	570	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	160	rrsB_13	1528	251	90.51	rrsB_13.l15.c4.ctg.1	626	0.0	0	.	n	.	0	G201T	SNP	201	201	G	573	573	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	160	rrsB_13	1528	251	90.51	rrsB_13.l15.c4.ctg.1	626	0.0	0	.	n	.	0	A204G	SNP	204	204	A	576	576	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	160	rrsB_13	1528	251	90.51	rrsB_13.l15.c4.ctg.1	626	0.0	0	.	n	.	0	G206T	SNP	206	206	G	578	578	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	160	rrsB_13	1528	251	90.51	rrsB_13.l15.c4.ctg.1	626	0.0	0	.	n	.	0	.211GC	INS	211	211	A	584	584	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	160	rrsB_13	1528	251	90.51	rrsB_13.l15.c4.ctg.1	626	0.0	0	.	n	.	0	T217A	SNP	217	217	T	591	591	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	160	rrsB_13	1528	251	90.51	rrsB_13.l15.c4.ctg.1	626	0.0	0	.	n	.	0	G231A	SNP	231	231	G	605	605	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	160	rrsB_13	1528	863	98.15	rrsB_13.l15.c4.ctg.2	1105	0.0	0	.	n	.	0	C990.	DEL	990	990	C	324	324	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	160	rrsB_13	1528	863	98.15	rrsB_13.l15.c4.ctg.2	1105	0.0	0	.	n	.	0	G993T	SNP	993	993	G	327	327	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	160	rrsB_13	1528	863	98.15	rrsB_13.l15.c4.ctg.2	1105	0.0	0	.	n	.	0	.994T	INS	994	994	C	329	329	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	160	rrsB_13	1528	863	98.15	rrsB_13.l15.c4.ctg.2	1105	0.0	0	.	n	.	0	T1002G	SNP	1002	1002	T	338	338	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	160	rrsB_13	1528	863	98.15	rrsB_13.l15.c4.ctg.2	1105	0.0	0	.	n	.	0	G1004.	DEL	1004	1004	G	339	339	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	160	rrsB_13	1528	863	98.15	rrsB_13.l15.c4.ctg.2	1105	0.0	0	.	n	.	0	T1117A	SNP	1117	1117	T	452	452	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	160	rrsB_13	1528	863	98.15	rrsB_13.l15.c4.ctg.2	1105	0.0	0	.	n	.	0	T1248C	SNP	1248	1248	T	583	583	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	160	rrsB_13	1528	863	98.15	rrsB_13.l15.c4.ctg.2	1105	0.0	0	.	n	.	0	G1254T	SNP	1254	1254	G	589	589	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	160	rrsB_13	1528	863	98.15	rrsB_13.l15.c4.ctg.2	1105	0.0	0	.	n	.	0	G1255A	SNP	1255	1255	G	590	590	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	160	rrsB_13	1528	863	98.15	rrsB_13.l15.c4.ctg.2	1105	0.0	0	.	n	.	0	T1265.	DEL	1265	1265	T	599	599	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	160	rrsB_13	1528	863	98.15	rrsB_13.l15.c4.ctg.2	1105	0.0	0	.	n	.	0	C1268A	SNP	1268	1268	C	602	602	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	160	rrsB_13	1528	863	98.15	rrsB_13.l15.c4.ctg.2	1105	0.0	0	.	n	.	0	G1421A	SNP	1421	1421	G	755	755	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	160	rrsB_13	1528	863	98.15	rrsB_13.l15.c4.ctg.2	1105	0.0	0	.	n	.	0	T1437.	DEL	1437	1437	T	770	770	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	160	rrsB_13	1528	863	98.15	rrsB_13.l15.c4.ctg.2	1105	0.0	0	.	n	.	0	C1447T	SNP	1447	1447	C	780	780	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	160	rrsB_13	1528	863	98.15	rrsB_13.l15.c4.ctg.2	1105	0.0	1	SNP	n	G1475A	0	.	.	1475	1475	G	808	808	G	ND	ND	ND	rrsB.3003547.NC_008596.1.5027948_5029475.3248:0:0:G1475A:.:b'Point mutations in the helix 44 region of the 16S rRNA rrsB gene of Mycolicibacterium smegmatis can confer resistance to viomycin.'	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	160	rrsB_13	1528	863	98.15	rrsB_13.l15.c4.ctg.2	1105	0.0	1	SNP	n	G1475U	0	.	.	1475	1475	G	808	808	G	ND	ND	ND	rrsB.3003547.NC_008596.1.5027948_5029475.3248:0:0:G1475U:.:b'Point mutations in the helix 44 region of the 16S rRNA rrsB gene of Mycolicibacterium smegmatis can confer resistance to viomycin.'	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	478	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1352	0.0	1	SNP	p	T22A	0	.	.	64	66	ACC	220	222	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:T22A:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	478	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1352	0.0	1	SNP	p	Y36C	0	.	.	106	108	TAT	262	264	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:Y36C:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	478	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1352	0.0	1	SNP	p	H75N	0	.	.	223	225	CAC	379	381	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:H75N:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	478	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1352	0.0	1	SNP	p	V77F	0	.	.	229	231	GTC	385	387	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:V77F:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	478	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1352	0.0	1	SNP	p	W83C	0	.	.	247	249	TGG	403	405	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:W83C:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	478	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1352	0.0	1	SNP	p	G91R	0	.	.	271	273	GGG	427	429	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:G91R:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	478	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1352	0.0	1	SNP	p	W101R	0	.	.	301	303	TGG	457	459	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:W101R:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	478	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1352	0.0	1	SNP	p	S105P	0	.	.	313	315	TCC	469	471	TCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:S105P:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	478	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1352	0.0	1	SNP	p	R126Q	0	.	.	376	378	CGG	532	534	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:R126Q:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	478	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1352	0.0	1	SNP	p	F152V	0	.	.	454	456	TTC	610	612	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:F152V:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	478	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1352	0.0	1	SNP	p	C161T	0	.	.	481	483	TGT	637	639	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:C161T:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	478	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1352	0.0	1	SNP	p	T202A	0	.	.	604	606	ACC	760	762	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:T202A:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	478	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1352	0.0	1	SNP	p	H207R	0	.	.	619	621	CAC	775	777	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:H207R:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	478	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1352	0.0	1	SNP	p	P224L	0	.	.	670	672	CCG	826	828	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:P224L:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	478	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1352	0.0	1	SNP	p	R235P	0	.	.	703	705	CGG	859	861	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:R235P:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	420	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1278	0.0	1	SNP	p	R14W	0	.	.	40	42	CGG	134	136	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:R14W:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	420	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1278	0.0	1	SNP	p	A67E	0	.	.	199	201	GCG	293	295	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:A67E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	420	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1278	0.0	1	SNP	p	K69E	0	.	.	205	207	AAA	299	301	AAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:K69E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	420	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1278	0.0	1	SNP	p	A91E	0	.	.	271	273	GCA	365	367	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:A91E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	420	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1278	0.0	1	SNP	p	L118P	0	.	.	352	354	CTG	446	448	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:L118P:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	420	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1278	0.0	1	SNP	p	V128E	0	.	.	382	384	GTG	476	478	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:V128E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	420	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1278	0.0	1	SNP	p	L150P	0	.	.	448	450	CTG	542	544	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:L150P:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	420	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1278	0.0	1	SNP	p	P183L	0	.	.	547	549	CCG	641	643	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:P183L:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	420	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1278	0.0	1	SNP	p	F185L	0	.	.	553	555	TTT	647	649	TTT	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:F185L:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	420	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1278	0.0	1	SNP	p	N236K	0	.	.	706	708	AAT	800	802	AAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:N236K:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	420	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1278	0.0	1	SNP	p	E238K	0	.	.	712	714	GAG	806	808	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:E238K:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
